Marie-alix A. Derieppe

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.

Journal: iScience

Published: November 19, 2024

Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression.

Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 13, 2024

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.

Journal: Translational oncology

Published: August 06, 2024

Resveratrol and capsaicin as safer radiosensitizers for colorectal cancer compared to 5-fluorouracil.

Resveratrol and capsaicin as safer radiosensitizers for colorectal cancer compared to 5-fluorouracil.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 12, 2024

PTP4A2 Promotes Glioblastoma Progression and Macrophage Polarization under Microenvironmental Pressure.

PTP4A2 Promotes Glioblastoma Progression and Macrophage Polarization under Microenvironmental Pressure.

Journal: Cancer research communications

Published: August 03, 2023

Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis.

Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis.

Journal: Cellular and molecular life sciences : CMLS

Published: July 24, 2023

Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas.

Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 23, 2023

THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1.

THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1.

Journal: Cell reports

Published: April 19, 2023

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications.

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications.

Journal: Experimental hematology & oncology

Published: December 27, 2022

Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model.

Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 02, 2022

Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development.

Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development.

Journal: Cancers

Published: June 01, 2022

An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid.

An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid.

Journal: Cancers

Published: March 30, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026